To Evaluate the Delivery Timing Safety and Efficacy of AntiTachycardia Pacing (BIO|ATP)

NCT05426785 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

398

Enrollment

INDUSTRY

Sponsor class

Conditions

Implantable Cardioverter Defibrillator(ICD)

Interventions

DEVICE: 1:1 ratio for Treatment Group and Control Group

Sponsor

Biotronik SE & Co. KG

Collaborators

[object Object]